Order Article Reprints

Hunter E, Alshaker H, Weston C, Issa M, Bautista S, Gebregzabhar A, Virdi A, Dring A, Powell R, Green J, et al. A New Blood-Based Epigenetic Diagnostic Biomarker Test (EpiSwitch^®® NST) with High Sensitivity and Positive Predictive Value for Colorectal Cancer and Precancerous Polyps. Cancers. 2025; 17(3):521. https://doi.org/10.3390/cancers17030521

Hunter, Ewan, Heba Alshaker, Cicely Weston, Mutaz Issa, Shekinah Bautista, Abel Gebregzabhar, Anya Virdi, Ann Dring, Ryan Powell, Jayne Green, and et al. 2025. "A New Blood-Based Epigenetic Diagnostic Biomarker Test (EpiSwitch^®® NST) with High Sensitivity and Positive Predictive Value for Colorectal Cancer and Precancerous Polyps" Cancers 17, no. 3: 521. https://doi.org/10.3390/cancers17030521

Hunter, E., Alshaker, H., Weston, C., Issa, M., Bautista, S., Gebregzabhar, A., Virdi, A., Dring, A., Powell, R., Green, J., Lal, R., Velchuru, V., Aryal, K., Bin Abu Hassan, M. R., Meng, G. T., Patel, J. S., Mohamed Gani, S. P., Lim, C. R., Guiel, T., ... Pchejetski, D. (2025). A New Blood-Based Epigenetic Diagnostic Biomarker Test (EpiSwitch^®® NST) with High Sensitivity and Positive Predictive Value for Colorectal Cancer and Precancerous Polyps. Cancers, 17(3), 521. https://doi.org/10.3390/cancers17030521